RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management
Ross M. Fasano(Emory University), Willy A. Flegel(National Institutes of Health Clinical Center), John Otridge, Naynesh Kamani(American Association of Blood Banks), Harvey G. Klein(National Institutes of Health Clinical Center), Francesco M. Marincola(Center for Translational Molecular Medicine), Philippe Pary(Children's National), David F. Stroncek(Yale University), A. Hallie Lee‐Stroka(Boston University), Emily Riehm Meier(Indiana Hemophilia and Thrombosis Center), Naomi L.C. Luban(National Institutes of Health), Alessandro Monaco(National Institutes of Health)
Cited by 46
Related Papers
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
|Journal for ImmunoTherapy of Cancer|2020|1k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Red blood cell transfusion in clinical practice
|The Lancet|2007|484
Molecular Basis of Weak D Phenotypes
|Blood|1999|336
Molecular Basis of Weak D Phenotypes
|Blood|1999|331